Gene expression profile of endothelin-1-induced growth in glomerular mesangial cells

被引:15
作者
Mishra, R
Leahy, P
Simonson, MS
机构
[1] Case Western Reserve Univ, Univ Hosp Cleveland, Dept Med, Div Nephrol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, CWRU Canc Ctr, Cleveland, OH 44106 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 2003年 / 285卷 / 05期
关键词
proliferation; heparin-binding epidermal growth factor-like; growth factor; microarray;
D O I
10.1152/ajpcell.00105.2003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Endothelin (ET)-1 is a vasoconstrictor and mitogen involved in vascular remodeling. Changes in gene expression that underlie control of cell growth by ET-1 remain poorly characterized. To identify pathways of growth control we used microarrays to analyze ET-1-regulated gene expression in human mesangial cells, an important ET-1 vascular target cell in vivo. Statistical assessment of differential expression (significance analysis of microarrays) revealed upregulated transcripts for growth factors [heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF), fibroblast growth factor (FGF), interleukin (IL)-6] and downregulated transcripts for genes that inhibit growth (BAX, p27KIP1, DAD1). Consistent with the gene expression profile, quantitative RT-PCR and Western blotting confirmed induction of HB-EGF by ET-1. To test a functional role for HB-EGF in ET-1 signaling, we showed that exogenous HB-EGF stimulated phosphorylation of ErbB1 and growth of mesangial cells. ET-1-induced proliferation was blocked by an ErbB1 receptor-selective kinase inhibitor and by a specific ErbB1 receptor-neutralizing antibody. Proliferation in response to ET-1 was also inhibited by neutralizing antisera against human HB-EGF. Together, these results provide data for modeling ET-1 pathways for growth control and suggest a specific role for HB-EGF gene induction in mesangial cell growth in response to ET-1.
引用
收藏
页码:C1109 / C1115
页数:7
相关论文
共 33 条
[1]   Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy [J].
Asakura, M ;
Kitakaze, M ;
Takashima, S ;
Liao, Y ;
Ishikura, F ;
Yoshinaka, T ;
Ohmoto, H ;
Node, K ;
Yoshino, K ;
Ishiguro, H ;
Asanuma, H ;
Sanada, S ;
Matsumura, Y ;
Takeda, H ;
Beppu, S ;
Tada, M ;
Hori, M ;
Higashiyama, S .
NATURE MEDICINE, 2002, 8 (01) :35-40
[2]   Gene Ontology: tool for the unification of biology [J].
Ashburner, M ;
Ball, CA ;
Blake, JA ;
Botstein, D ;
Butler, H ;
Cherry, JM ;
Davis, AP ;
Dolinski, K ;
Dwight, SS ;
Eppig, JT ;
Harris, MA ;
Hill, DP ;
Issel-Tarver, L ;
Kasarskis, A ;
Lewis, S ;
Matese, JC ;
Richardson, JE ;
Ringwald, M ;
Rubin, GM ;
Sherlock, G .
NATURE GENETICS, 2000, 25 (01) :25-29
[3]   Endothelin antagonists in renal disease [J].
Benigni, A ;
Madias, NE ;
Remuzzi, G ;
Siragy, HM ;
Brooks, DP ;
Rossi, GP ;
Abbate, M ;
Ong, A ;
Loeffler, BM ;
Bender, N ;
Noris, M ;
Ruggenenti, P ;
Wilson, C .
KIDNEY INTERNATIONAL, 2000, 57 (04) :1778-1794
[4]   Regression of renal vascular fibrosis by endothelin receptor antagonism [J].
Boffa, JJ ;
Tharaux, PL ;
Dussaule, JC ;
Chatziantoniou, C .
HYPERTENSION, 2001, 37 (02) :490-496
[5]   Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice - Role of endothelin [J].
Chatziantoniou, C ;
Boffa, JJ ;
Ardaillou, R ;
Dussaule, JC .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (12) :2780-2789
[6]   Signal characteristics of G protein-transactivated EGF receptor [J].
Daub, H ;
Wallasch, C ;
Lankenau, A ;
Herrlich, A ;
Ullrich, A .
EMBO JOURNAL, 1997, 16 (23) :7032-7044
[7]   Pleiotropic coupling of G protein-coupled receptors to the mitogen-activated protein kinase cascade - Role of focal adhesions and receptor tyrosine kinases [J].
Della Rocca, GJ ;
Maudsley, S ;
Daaka, Y ;
Lefkowitz, RJ ;
Luttrell, LM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (20) :13978-13984
[8]  
Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495
[9]   Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells [J].
Eguchi, S ;
Numaguchi, K ;
Iwasaki, H ;
Matsumoto, T ;
Yamakawa, T ;
Utsunomiya, H ;
Motley, ED ;
Kawakatsu, H ;
Owada, KM ;
Hirata, Y ;
Marumo, F ;
Inagami, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (15) :8890-8896
[10]   Cluster analysis and display of genome-wide expression patterns [J].
Eisen, MB ;
Spellman, PT ;
Brown, PO ;
Botstein, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14863-14868